Reproductive Hormones and Skeletal Health in Young Women
Open Access
- 1 April 2008
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (4), 1175-1177
- https://doi.org/10.1210/jc.2008-0379
Abstract
In young women, low estrogen levels complicate a wide variety of diseases, including premature ovarian failure, anorexia nervosa, athletic amenorrhea, prolactinoma, hypopituitarism, and chronic kidney disease. Hypoestrogenemia may also result from therapy with GnRH agonists, glucocorticosteroids, chemotherapy, and especially aromatase inhibitors. All of these situations are associated with bone loss, because estrogen chronically suppresses bone resorption. Several mechanisms are involved: 1) estrogen increases osteoclast apoptosis; 2) by suppressing interleukins and proinflammatory cytokine expression in bone marrow cells, estrogen decreases the number of osteoclasts; 3) by inhibiting the production of receptor activator of nuclear factor-κB ligand, estrogen reduces the number and activity of osteoclasts; and 4) by increasing stromal cell/osteoblast cell expression of TGFβ, estrogen inhibits osteoclast activity. Estrogen also has some positive effects on bone formation by acting as a mitogen to cells early in the osteoblast line, reducing apoptosis of osteoblasts, and increasing expression of TGFβ, bone morphogenetic proteins, and IGF-I (1).Keywords
This publication has 20 references indexed in Scilit:
- Effects of Depot Medroxyprogesterone Acetate on Bone Density and Bone Metabolism before and after Peak Bone Mass: A Case-Control StudyJournal of Clinical Endocrinology & Metabolism, 2008
- A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and MenJournal of Bone and Mineral Research, 2008
- Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilitiesWomen's Health Issues, 2006
- Association Between Bone Mass and Fractures in Children: A Prospective Cohort StudyJournal of Bone and Mineral Research, 2006
- Calcitonin Plays a Critical Role in Regulating Skeletal Mineral Metabolism during LactationEndocrinology, 2006
- Depot Medroxyprogesterone Acetate and Bone Mineral Density in Adolescents—The Black Box Warning: A Position Paper of the Society for Adolescent MedicineJournal of Adolescent Health, 2006
- Combined hormonal contraception and bone health: a systematic reviewContraception, 2006
- Progestogen-only contraception and bone mineral density: a systematic reviewContraception, 2006
- Change in Bone Mineral Density Among Adolescent Women Using and Discontinuing Depot Medroxyprogesterone Acetate ContraceptionArchives of Pediatrics & Adolescent Medicine, 2005
- Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraceptionAmerican Journal of Obstetrics and Gynecology, 2005